
Ventas, Inc. company profile
$88.37−0.57%Close 17 Nov 2026 · Market value $46.47B
About Ventas, Inc.
Ventas, Inc. is a real estate investment trust that owns and invests in healthcare properties, operating through three reportable segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). As of December 31, 2025, it owned or had investments in 1,409 properties located in North America and the United Kingdom. The SHOP segment includes independent living, assisted living, memory care and continuing care retirement communities, operated through third-party managers. OM&R comprises outpatient medical buildings and research centers leased to health systems, medical practices, universities and life science companies. NNN leases senior housing, skilled nursing facilities, long-term acute care facilities, inpatient rehabilitation facilities and other healthcare facilities to operators. The company is headquartered in Chicago, Illinois.
A summary of the business section of the company's latest annual report, filed 6 Feb 2026.
Company facts
| Ticker | VTR · NYSE |
|---|
| Sector | Real estate |
|---|
| Industry | Health Care REITs |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 740260 |
|---|
| Latest annual report | 10-K, filed 6 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Debra A. Cafaro | Chairman and CEO · Director | 1.8M · < 1% | Shares withheld for tax, 11 Feb 2026 |
|---|
| J. Justin Hutchens | EVP Senior Housing and CIO | 156K · < 1% | Grant or award, 11 Feb 2026 |
|---|
| Robert F. Probst | EVP and CFO | 126K · < 1% | Grant or award, 11 Feb 2026 |
|---|
| Peter J. Bulgarelli | EVP OM&R-Ventas/Pres&CEO-LHS | 114K · < 1% | Shares withheld for tax, 1 May 2026 |
|---|
| Matthew J. Lustig | Director | 89.3K · < 1% | Grant or award, 15 Oct 2026 |
|---|
| Carey S. Roberts | EVP and GC | 74.3K · < 1% | Shares withheld for tax, 11 Feb 2026 |
|---|
| Roxanne M. Martino | Director | 60.4K · < 1% | Grant or award, 30 Oct 2026 |
|---|
| Walter C. Rakowich | Director | 24.6K · < 1% | Sale under a 10b5-1 plan, 14 May 2026 |
|---|
| Melody C. Barnes | Director | 22.2K · < 1% | Grant or award, 15 Oct 2026 |
|---|
| Sean P. Nolan | Director | 21.4K · < 1% | Grant or award, 13 May 2026 |
|---|
| Maurice S. Smith | Director | 13.3K · < 1% | Grant or award, 30 Oct 2026 |
|---|
| Marguerite M. Nader | Director | 10.4K · < 1% | Grant or award, 15 Oct 2026 |
|---|
| Michael J. Embler | Director | 9.3K · < 1% | Grant or award, 15 Oct 2026 |
|---|
| Theodore R. Bigman | Director | 5.7K · < 1% | Grant or award, 13 May 2026 |
|---|
| Sumit Roy | Director | 4.3K · < 1% | Grant or award, 15 Oct 2026 |
|---|
| Joe V. Rodriguez, Jr. | Director | 1.0K · < 1% | Grant or award, 15 Oct 2026 |
|---|
| Sayed Laurida | SVP, Chief Accounting Officer | — | Grant or award, 5 Oct 2026 |
|---|
| Wattula Andy | EVP OM&R-Ventas/Pres&CEO-LHS | — | Grant or award, 1 Aug 2026 |
|---|
| Liebbe Gregory R | SVP, Chief Accounting Officer | — | Shares withheld for tax, 5 Apr 2025 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
VTR in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.